Effect of Freezing Phenomenon in Patients With Parkinson's Disease
Investigation of the Effect of Freezing Phenomenon on Gait Parameters and Pedobarographic Pressure Distribution in Patients With Parkinson's Disease
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Büşra Seçkinoğulları Korkusuz, MSc
- Phone Number: 05442436914
- Email: busrasec@gmail.com
Study Locations
-
-
-
Ankara, Turkey
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Volunteering to participate in the study
- Being between stage 2-3 according to the Modified Hoehn-Yahr Staging Scale
- Having a score of 24 or above from the Standardized Mini Mental Test
Exclusion Criteria:
- Presence of an additional neurological or psychiatric disease other than Parkinson's disease
- Presence of uncontrollable dyskinesia or motor fluctuations
- Presence of postural hypotension, vision problems (that cannot be compensated with the correct lens) or vestibular disorders that may affect balance
- Presence of cardiopulmonary diseases that may affect walking
- Presence of orthopedic problems and inflammatory arthritis (such as fractures, osteoporosis, osteomyelitis) that may cause limitation of movement and affect gait and evaluations
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Healthy
|
|
Parkinson's patients with freezing phenomenon
|
|
Parkinson's patients without freezing phenomenon
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Computerized Gait Evaluation System
Time Frame: Baseline
|
This system allows the measurement of spatiotemporal features of gait.
|
Baseline
|
|
Pressure distribution measurement platform
Time Frame: Baseline
|
This system allows the measurement of dynamic foot pressure distribution with the pressure distribution measurement platform integrated into the system
|
Baseline
|
|
Kinematic analysis
Time Frame: Baseline
|
Kinematic analysis of the gait can be performed with the camera support within the system.
|
Baseline
|
|
The freezing of gait questionnaire
Time Frame: Baseline
|
This scale is a scale that evaluates freezing.
This scale is related to patients' experiences, especially in the last week.
One article describes the frequency of freezing seen in patients.
|
Baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Emine Nur Demircan, Msc, Hacettepe University
- Study Chair: Ayla Fil Balkan, Assoc.Prof, Hacettepe University
- Study Chair: Bülent Elibol, Prof.Dr., Hacettepe University
- Principal Investigator: Süleyman Korkusuz, PhD, Atılım University
- Study Chair: Büşra Seçkinoğulları Korkusuz, MSc, Ankara University
- Study Chair: Ayşenur Özcan, Çankırı Karatekin University
- Study Chair: Ferdi Yavuz, Assoc.Prof, European University of Lefke
- Study Chair: Gül Yalçın Çakmaklı, Assoc.Prof, Hacettepe University
Publications and helpful links
General Publications
- Morris ME, Iansek R, Matyas TA, Summers JJ. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain. 1994 Oct;117 ( Pt 5):1169-81. doi: 10.1093/brain/117.5.1169.
- Giladi N, Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov Disord. 2008;23 Suppl 2:S423-5. doi: 10.1002/mds.21927. No abstract available. Erratum In: Mov Disord. 2008 Aug 15;23(11):1639-40.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- e2d1895a2fd54888
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.